Posted inComunicati
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE - First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and…









